Editor’s Note
This article highlights a significant shift in India’s pharmaceutical sector. While long recognized as a global leader in generic drug manufacturing, the industry has traditionally relied on imported machinery. The emergence of an Indian firm producing world-standard pharmaceutical equipment marks a pivotal step toward greater self-reliance and could reshape the global supply chain for essential medicines.
When you talk about the Pharma Industry, India is far ahead in manufacturing Generic Drugs. Not only third-world countries but also developed nations like the USA and Canada import medicines from here. However, if you visit the factory of any world-class pharma company, you will find most of the machinery is made in European countries. But this will not be the case anymore. An Indian company has now started manufacturing world-standard machinery for making drugs, capsules, injections, and even packaging, right in India. Because they are made in India, the price of these machines is extremely low.
The Dadachanji Group, a group involved in pharmaceutical manufacturing and allied technology, is based in the Union Territory of Daman. This very group recently launched a new company named Kairish Innotech. It is reported that this is a next-generation engineering and technology company that has started building fully customized machines for sectors like pharma and healthcare. Customized machines mean the machine is designed and manufactured according to the customer’s requirements.
This was stated by Kairus Dadachanji, Chairman of the Dadachanji Group. He added that this will make the pharma sector even more competitive and reduce their costs.
People associated with this field say that most machinery in the pharma sector comes from European countries. These machines are perfectly fit in terms of quality and standards. They meet standards from WHO to American norms. But they are expensive. Also, if there is any problem with those machines, engineers and technicians have to be called from Europe. Sometimes, it takes months for spare parts to arrive. Production remains halted until then.
Kairus Dadachanji says that now European standard machines will be available at Indian prices. Giving an example of a machine that fills injections into vials and ampules, he explained that if such a machine is imported from Switzerland, its cost is around 70 crore rupees. But in India, they are selling it for just 20 crore rupees.
The good thing is that the R&D for these machines is done in-house, so there is no need to pay royalties to any multinational company. Companies will also get after-sales service and spare parts for these machines immediately.